MedTrace Logo

Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy

NCT04134104 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2023-11-13

No results posted yet for this study

Summary

Colorectal cancer is the second most common cancer by the site in Europe and the third most common cancer in the USA with high morbidity and mortality. Survival after the treatment has improved over the past few decades as a result of early diagnosis, radiotherapy, and advances in surgical techniques such as abdominoperineal resection (APR), low anterior resection (LAR) and total mesorectal excision (TME). These innovative surgeries are the current standard treatment for the mid and the low rectal cancers which avoids the permanent colostomy. It is very difficult to find out the incidence of the bowel, bladder and sexual dysfunction of patients either because they are embarrassed or because they do not relate their symptoms to rectal cancer treatment. This article reports the incidence of the bowel, bladder and sexual dysfunction following surgery for rectal cancer from the National Academy of Medical Sciences, Bir Hospital, a tertiary level hospital.

Conditions

  • Bowel Dysfunction
  • Bladder Dysfunction
  • Sexual Dysfunction
  • Colorectal Surgery

Interventions

PROCEDURE

Surgery for Colorectal malignant diseases either LAR or APR

Patients following LAR or APR were observed for the Bowel, Bladder, and Sexual Dysfunction

Sponsors & Collaborators

  • National Academy of Medical Sciences, Nepal

    lead OTHER_GOV

Principal Investigators

  • Nabin Pokharel, MCh · Bir Hospital

  • Gaurav Katwal, MS · Bir Hospital

  • Subodh K Adhikari, MS · Bir Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2017-12-31
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04134104 on ClinicalTrials.gov